Tenon Medical Shareholders Approve Reverse Split and Financings
TipRanks (Fri, 24-Jul 5:19 PM ET)
Tenon Medical Regains Nasdaq Listing Compliance After Offering
TipRanks (Mon, 20-Jul 8:48 AM ET)
Tenon Medical regains Nasdaq compliance
Seeking Alpha News (Mon, 20-Jul 8:17 AM ET)
Tenon Medical, Inc. Announces Regained Compliance with Nasdaq Stockholders' Equity Requirement
ACCESS Newswire (Mon, 20-Jul 8:00 AM ET)
Tenon Medical(R) Announces FDA 510(k) Clearance for Catamaran(R) SI Joint Fusion System
ACCESS Newswire (Thu, 2-Jul 8:00 AM ET)
WallachBeth Capital Announces Closing of Tenon Medical, Inc. $4.2 Million Public Offering
PRNewswire (Wed, 1-Jul 12:46 PM ET)
Tenon Medical, Inc. Announces Closing of $4.2 Million Public Offering
ACCESS Newswire (Wed, 1-Jul 12:10 PM ET)
WallachBeth Capital Announces Pricing of Tenon Medical, Inc. $4.2 Million Public Offering
PRNewswire (Tue, 30-Jun 10:00 AM ET)
Tenon Medical, Inc. Announces Pricing of $4.2 Million Public Offering
ACCESS Newswire (Tue, 30-Jun 9:25 AM ET)
Tenon(R) Medical Reports First Quarter 2026 Financial Results
ACCESS Newswire (Tue, 12-May 4:05 PM ET)
Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
Tenon Medical trades on the NASDAQ stock market under the symbol TNON.
As of July 24, 2026, TNON stock price declined to $0.19 with 192,669 million shares trading.
TNON has a beta of -0.77, meaning it tends to be less sensitive to market movements. TNON has a correlation of 0.01 to the broad based SPY ETF.
TNON has a market cap of $3.30 million. This is considered a Sub-Micro Cap stock.
Last quarter Tenon Medical reported $1 million in Revenue and -$.31 earnings per share. This beat revenue expectation by $83,500 and missed earnings estimates by -$.01.
In the last 3 years, TNON traded as high as $37.60 and as low as $.18.
The top ETF exchange traded funds that TNON belongs to (by Net Assets): VXF.
TNON has underperformed the market in the last year with a price return of -82.6% while the SPY ETF gained +17.7%. TNON has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -76.4% and -15.9%, respectively, while the SPY returned +3.8% and -2.1%, respectively.
TNON support price is $.18 and resistance is $.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TNON shares will trade within this expected range on the day.